Indocyanine green elimination patients liver disease normal subjects validity two-compartment pharmacokinetic model estimation hepatic extraction ratio Indocyanine Green patients cirrhosis liver agreement value hepatic extraction ratio two-compartment model reasons failure model extended sampling period time course Indocyanine Green plasma healthy subjects patients cirrhosis liver bolus injection dye Indocyanine Green measurable plasma injection healthy subjects injection patients plasma elimination curve groups triexponential function clearance Indocyanine Green data first min injection data Indocyanine Green measurable plasma patients cirrhosis mean overestimate two-compartment pharmacokinetic model inappropriate description disposition Indocyanine Green estimates hepatic extraction ratio model patients cirrhosis inaccurate 